Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014

BACKGROUND: Over the past 20 years, the mechanisms of action, duration of benefits and economic costs of newly licenced cancer drugs have changed significantly; however, summary data on these characteristics are limited. METHODS: In this study, using historical copies of the British National Formula...

Descripción completa

Detalles Bibliográficos
Autores principales: Savage, P, Mahmoud, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366897/
https://www.ncbi.nlm.nih.gov/pubmed/25668005
http://dx.doi.org/10.1038/bjc.2015.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366897/
https://www.ncbi.nlm.nih.gov/pubmed/25668005
http://dx.doi.org/10.1038/bjc.2015.56

Ejemplares similares